The neuroprotective effects of (-)deprenyl in the gerbil hippocampus following transient global ischemia

Journal of Neural Transmission

Volumn 107, Issue 7, 2000, Pages 779-786

  Kuhmonen, J ^a   Jolkkonen, J ^a   Haapalinna, A ^b   Sivenius, J ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ORION CORPORATION   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

( )Deprenyl; Gerbil; Global ischemia; Hippocampus; Neuroprotection

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MONOAMINE OXIDASE B INHIBITOR; SELEGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; GERBIL; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; FEMALE; GERBILLINAE; HIPPOCAMPUS; MONOAMINE OXIDASE INHIBITORS; PYRAMIDAL CELLS; SELEGILINE;

EID: 0033924730     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070058     Document Type: Article

References (31)

1. Ansari KS, Yu PH, Kruck TPA, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13: 4042-4053
2. Ballabriga, J, Pellisé A, Ferrer I (1997) L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones ungiculatus). J Neurol Sci 148: 1-5
3. Biagini G, Frasoldati A, Fuxe K, Agnati LF (1994) The concept of astrocyte-kinetic drugs in the treatment of neurodegenerative diseases: evidence for I-deprenyl-induced activation of reactive astrocytes. Neurochem Int 25: 17-22
4. Carrillo MC, Kanai S, Sato Y, Ivy GO, Kitani K (1992) Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats. Biochem Pharmacol 44: 2185-2189
5. Cheng B, Mattson MP (1991) NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7: 1031-1044
6. Colbourne F, Corbett D (1995) Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 15: 7250-7260
7. Ekblom J, Jossan SS, Ebendal T, Söderstöm S, Oreland L, Aquilonius S-M (1994) mRNA expression of neurotrophins and members of the trk family in the rat brain after treatment with L-deprenyl. Acta Neurol Scand 89: 147-148
8. Freund TF, Buzsaki G, Leon A, Somogyi P (1990) Hippocampal cell death following ischemia: effect of brain temperature and anesthesia. Exp Neurol 108: 251-260
9. Gallyas F, Wolff JR, Bottcher H, Zaborszky L (1980) A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol 55: 299-306
10. Ito U, Spatz M, Walker JT, Jr, Klatzo I (1975) Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations. Acta Neuropathol (Berl) 32: 209-223
11. Kirino T, Sano K (1984) Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol (Berl) 62: 209-218
12. Knollema S, Aukema W, Hom H, Korf J, Ter Horst GJ (1995) L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke 26: 1883-1887
13. Kotti T, Halonen T, Sirviö J, Riekkinen Sr P, Miettinen R (1997) Comparison of NADPH diaphorase histochemistry, somatostatin immunohistochemistry, and silver impregnation in detecting structural and functional impairment in experimental status epilepticus. Neuroscience 80: 105-117
14. Lahtinen H, Koistinaho J, Kauppinen R, Haapalinna A, Keinänen R, Sivenius J (1997) Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus. Brain Res 757: 260-267
15. +)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett 224: 197-200
16. Lorez H, Keller F, Ruess G, Otten U (1989) Nerve growth factor increases in adult rat brain after hypoxic injury. Neurosci Lett 98: 339-344
17. Matsui Y, Kumagae Y (1991) Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia. Neurosci Lett 126: 175-178
18. Nicoll RA, Madison DV, Lancaster B (1987) Noradrenergic modulation of neuronal excitability in mammalian hippocampus. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 105-112
19. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15: 1001-1011
20. Paetsch PR, Greenshaw AJ (1993) Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine. Cell Mol Neurobiol 13: 203-215
21. The Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328: 176-183
22. Pechan PA, Yoshida T, Panahian N, Moskowitz MA, Breakefield XO (1995) Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. NeuroReport 6: 669-672
23. Salo PT, Tatton WG (1992) Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res 31: 394-400
24. Salonen, T, Haapalinna A, Heinonen E, Suhonen J, Hervonen A (1996) Monoamine oxidase B inhibitor selegeline protects young and aged peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity. Acta Neuropathol (Berl) 91: 466-474
25. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336: 1216-1222
26. Semkova I, Wolz P, Schilling M, Krieglstein J (1996) Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol 315: 19-30
27. Thomas CE, Huber EW, Ohlweiler DF (1997) Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates. Free Rad Biol Med 22: 733-737
28. + in vivo. Eur J Pharmacol 243: 241-247
29. + dopaminergic toxicity. J Neural Transm 100: 53-61
30. Youdim MB, Finberg JP (1994) Pharmacological actions of 1-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors. Clin Pharmacol Ther 56: 725-733
31. Zhang X, Zuo DM, Davis BA, Boulton AA, Yu PH (1996) Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylinamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals. J Neurosci Res 43: 482-489